These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19825754)

  • 21. The application of new biosynthetic artificial skin for long-term temporary wound coverage.
    Wang HJ; Chou TD; Tsou TL; Chen TM; Chen SL; Chen SG; Wei LG; Yeh KJ; Ko YH; Wang CS; Lee WH
    Burns; 2005 Dec; 31(8):991-7. PubMed ID: 16274930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.
    Martin BR; Sangalang M; Wu S; Armstrong DG
    Int Wound J; 2005 Jun; 2(2):161-5. PubMed ID: 16722865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wound-healing protocols for diabetic foot and pressure ulcers.
    Brem H; Jacobs T; Vileikyte L; Weinberger S; Gibber M; Gill K; Tarnovskaya A; Entero H; Boulton AJ
    Surg Technol Int; 2003; 11():85-92. PubMed ID: 12931288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service.
    Alexandrescu V; Hubermont G; Philips Y; Guillaumie B; Ngongang Ch; Coessens V; Vandenbossche P; Coulon M; Ledent G; Donnay JC
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):448-56. PubMed ID: 19213580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of healing for postoperative diabetic foot wounds based on early wound area progression.
    Lavery LA; Barnes SA; Keith MS; Seaman JW; Armstrong DG
    Diabetes Care; 2008 Jan; 31(1):26-9. PubMed ID: 17934156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Special segment: soft tissue matrices--Apligraf bilayered skin substitute to augment healing of chronic wounds in diabetic patients.
    DeCarbo WT
    Foot Ankle Spec; 2009 Dec; 2(6):299-302. PubMed ID: 20400430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures.
    Lee DK
    J Foot Ankle Surg; 2007; 46(6):451-5. PubMed ID: 17980842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
    Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
    Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of fresh fibroblast allografts in the treatment of diabetic foot ulcers.
    Han SK; Kim HS; Kim WK
    Dermatol Surg; 2009 Sep; 35(9):1342-8. PubMed ID: 19500128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the reverse latissimus muscle flap for closure of complex back wounds in patients with spinal cord injury.
    Meiners T; Flieger R; Jungclaus M
    Spine (Phila Pa 1976); 2003 Aug; 28(16):1893-8. PubMed ID: 12923481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective management of major lower extremity wounds using an acellular regenerative tissue matrix: a pilot study.
    Brigido SA; Boc SF; Lopez RC
    Orthopedics; 2004 Jan; 27(1 Suppl):s145-9. PubMed ID: 14763548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous full-thickness skin substitute for healing chronic wounds.
    Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
    Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new wound-based severity score for diabetic foot ulcers: A prospective analysis of 1,000 patients.
    Beckert S; Witte M; Wicke C; Königsrainer A; Coerper S
    Diabetes Care; 2006 May; 29(5):988-92. PubMed ID: 16644625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human acellular dermal wound matrix: evidence and experience.
    Kirsner RS; Bohn G; Driver VR; Mills JL; Nanney LB; Williams ML; Wu SC
    Int Wound J; 2015 Dec; 12(6):646-54. PubMed ID: 24283346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To evaluate the efficacy of an acellular Flowable matrix in comparison with a wet dressing for the treatment of patients with diabetic foot ulcers: a randomized clinical trial.
    Campitiello F; Mancone M; Della Corte A; Guerniero R; Canonico S
    Updates Surg; 2017 Dec; 69(4):523-529. PubMed ID: 28497218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of noncontact normothermic wound therapy on the healing of neuropathic (diabetic) foot ulcers: an interim analysis of 20 patients.
    Alvarez OM; Rogers RS; Booker JG; Patel M
    J Foot Ankle Surg; 2003; 42(1):30-5. PubMed ID: 12567365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study.
    Brigido SA
    Int Wound J; 2006 Sep; 3(3):181-7. PubMed ID: 16984575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing.
    Nie C; Yang D; Morris SF
    Med Hypotheses; 2009 Jun; 72(6):679-82. PubMed ID: 19243892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds.
    Kahn SA; Beers RJ; Lentz CW
    J Burn Care Res; 2011; 32(1):124-8. PubMed ID: 21131847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable Nanomedical Scaffold Facilitates Healing of Chronic Lower Extremity Wounds.
    Regulski MJ; MacEwan MR
    Wounds; 2018 Aug; 30(8):E77-E80. PubMed ID: 30212370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.